US2016367727A1PendingUtilityA1
Systems for cartilage repair
Est. expiryMar 22, 2022(expired)· nominal 20-yr term from priority
A61K 35/12A61L 27/54A61F 2/28A61L 27/24C12N 2521/00A61L 27/56A61L 27/3817A61L 2300/64A61L 2430/06C12N 5/0655A61L 27/3843A61K 35/32A61L 27/3895A61F 2310/00365A61K 9/0024A61L 27/3852C12N 2533/54A61L 27/38A61L 27/3633
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
One-cartilage constructs suitable for implantation into a joint cartilage lesion in sit-up and a method for repair and restoration of function of injured, traumatic, aged or diseased cartilage. The construct comprises at least chondrocytes incorporated into a support matrix processed according to the algorithm comprising variable hydrostatic or atmospheric pressure or non-pressure conditions, variable rate of perfusion, variable medium composition, variable temperature, variable cell density and variable time to which the chondrocytes are subjected.
Claims
exact text as granted — not AI-modified1 .- 20 . (canceled)
21 . A method for preparing neo-cartilage, the method comprising:
providing a collagenous matrix comprising a plurality of pores; seeding the collagenous matrix with chondrocytes; culturing the seeded matrix at a hydrostatic pressure of at least about 0.5 MPA above atmospheric pressure for at least about 6 days; and resting the seeded matrix at atmospheric pressure for at least about 7 days, thereby preparing the neo-cartilage.
22 . The method of claim 21 , wherein the hydrostatic pressure is cyclic.
23 . The method of claim 22 , wherein the cyclic hydrostatic pressure is at a frequency between about 0.1 Hz and about 2.0 Hz.
24 . The method of claim 23 , further comprising perfusing the seeded matrix with a culture medium at a rate of perfusion between about 5 μL/min and about 50 μL/min.
25 . The method of claim 24 , wherein the cyclic hydrostatic pressure is less than about 10.0 MPA above atmospheric pressure.
26 . The method of claim 25 , wherein the seeded matrix is cultured at the cyclic hydrostatic pressure for less than about 60 days.
27 . The method of claim 26 , wherein the collagenous matrix further comprises at least a bioactive agent selected from the group consisting of a growth factor, a cytokine, and a peptide.
28 . The method of claim 26 , wherein the collagenous matrix comprises Type I collagen.
29 . The method of claim 26 , wherein the collagenous matrix comprises lyophilized collagen.
30 . A neo-cartilage product made by a process comprising:
providing a collagenous matrix comprising a plurality of pores; seeding the collagenous matrix with chondrocytes; culturing the seeded matrix at a hydrostatic pressure of at least about 0.5 MPA above atmospheric pressure for at least about 6 days; and resting the seeded matrix at atmospheric pressure for at least about 7 days.
31 . The neo-cartilage product of claim 30 , wherein the hydrostatic pressure comprises cyclic hydrostatic pressure applied to the seeded matrix at a frequency between about 0.1 Hz and about 2.0 Hz.
32 . The neo-cartilage product of claim 31 , wherein the cyclic hydrostatic pressure is less than about 10 MPa above atmospheric pressure.
33 . The neo-cartilage product of claim 32 , wherein the culturing further comprises perfusing the seeded matrix with a culture medium at a rate of perfusion between about 5 μL/min and about 50 μL/min.
34 . The neo-cartilage product of claim 33 , wherein the seeded matrix is cultured at the cyclic hydrostatic pressure for less than about 60 days.
35 . The neo-cartilage product of claim 34 , wherein the collagenous matrix further comprises at least one bioactive agent selected from the group consisting of a growth factor, a cytokine, and a peptide.
36 . The neo-cartilage product of claim 34 , wherein the collagenous matrix comprises Type I collagen.
37 . The neo-cartilage product of claim 34 , wherein the collagenous matrix comprises lyophilized collagen.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.